Zobrazeno 1 - 10
of 149
pro vyhledávání: '"Yasuo, Hozumi"'
Autor:
Azusa Morishita, Yasuo Hozumi, Hiroaki Ishii, Yukio Hokazono, Clovis Manuel Yosei Kikuchi, Megumi Shimasaki, Mikiko Itaya, Masaharu Oura, Ken Kuriki, Akira Hishida, George Seki
Publikováno v:
European Thyroid Journal, Vol 1, Iss 1, Pp 1-5 (2023)
Hypercalcemia due to parathyroid carcinoma (PC) is safely and quickly controlled with rapidly increasing evocalcet doses. Most parathyroid carcinomas are detected because of hypercalcemia due to primary hyperparathyroidism (PHPT). Hypercalcemia becom
Externí odkaz:
https://doaj.org/article/a9bae362f06c4b3096e2a9041a8d0c41
Publikováno v:
Case Reports in Oncology, Vol 14, Iss 3, Pp 1645-1651 (2021)
We report a rare case of hereditary breast and ovarian cancer syndrome (HBOC) with pathogenic variants in both BRCA1 and BRCA2. The patient was a 78-year-old woman who visited the hospital after noticing a lump in her left breast 6 months before, whi
Externí odkaz:
https://doaj.org/article/6961f3f571e445fcb40deee0405cbb68
Autor:
Miyuki Kitahara, Yasuo Hozumi, Naoto Takeuchi, Satoko Ichinohe, Saori Fujiwara, Mitsuki Machinaga, Hitoaki Saitoh, Tatsuo Iijima
Publikováno v:
Case Reports in Oncology, Vol 13, Iss 3, Pp 1196-1201 (2020)
In the absence of clear interstitial invasion, encapsulated papillary carcinoma (EPC) of the breast may be attributed to an extremely good prognosis if handled similarly to ductal carcinoma in situ (DCIS) with suitable local treatment. Here, we repor
Externí odkaz:
https://doaj.org/article/27ecd858d1ef4f12a1bbc6fc44581890
Autor:
Miyuki Kitahara, Yasuo Hozumi, Naoto Takeuchi, Satoko Ichinohe, Mitsuki Machinaga, Tatsuo Iijima
Publikováno v:
Case Reports in Oncology, Vol 13, Iss 3, Pp 1125-1130 (2020)
Invasive breast cancer deriving from the milk duct and lobule that develops in the nipple is extremely rare, except in Paget’s disease and skin cancer. This is the second reported case of the development of invasive cancer confined to the nipple af
Externí odkaz:
https://doaj.org/article/75b2bfbb31af4a98b5b555181a929f2b
Publikováno v:
Case Reports in Oncology, Vol 12, Iss 2, Pp 473-479 (2019)
Late recurrence of estrogen receptor (ER) positive breast cancer is common. When tissues from a recurrent or metastatic focus are available, re-evaluation of ER, progesterone receptor (PgR), and human epidermal growth factor receptor 2 (HER2) status
Externí odkaz:
https://doaj.org/article/dfb10db56b5f489ca038b194a7cff6c2
Publikováno v:
Case Reports in Oncology, Vol 11, Iss 3, Pp 609-614 (2018)
Bowen’s disease is a type of intraepidermal squamous cell carcinoma that commonly develops in areas of the skin exposed to sunlight, such as the scalp, trunk, and limbs. Although development of Bowen’s disease in other sites, such as the nipple,
Externí odkaz:
https://doaj.org/article/6a6813c6ed804ac08798def282c8e058
Publikováno v:
Case Reports in Oncology, Vol 11, Iss 2, Pp 318-322 (2018)
Intramammary metastasis of renal cell carcinoma (RCC) is extremely rare, accounting for only 1.5% of all intramammary metastases. Distinguishing intramammary metastases from benign tumors and breast cancer is clinically problematic. Some patients und
Externí odkaz:
https://doaj.org/article/6f5f43e2972141bbb82e0c9cd8f1a51b
Autor:
Takeru Shiroiwa, Takashi Fukuda, Kojiro Shimozuma, Mitsuko Mouri, Yasuhiro Hagiwara, Takuya Kawahara, Shozo Ohsumi, Yasuo Hozumi, Yoshiaki Sagara, Yasuo Ohashi, Hirofumi Mukai
Publikováno v:
BMC Cancer, Vol 17, Iss 1, Pp 1-10 (2017)
Abstract Background This study evaluated the cost-effectiveness of replacing standard intravenous therapy (taxane) with oral S-1 therapy for first-line metastatic breast cancer treatment. Methods This cost-effectiveness analysis was based on data fro
Externí odkaz:
https://doaj.org/article/ea9f16136db148b4babd5875bcf9af64
Autor:
Takuji Iwase, Shigehira Saji, Kotaro Iijima, Kenji Higaki, Shoichiro Ohtani, Yasuyuki Sato, Yasuo Hozumi, Yoshie Hasegawa, Yasuhiro Yanagita, Hiroyuki Takei, Maki Tanaka, Hideji Masuoka, Masahiko Tanabe, Chiyomi Egawa, Yoshifumi Komoike, Toshitaka Nakamura, Hiroshi Ohtsu, Hirofumi Mukai
Publikováno v:
Journal of Clinical Oncology.
PURPOSE Treatment with an aromatase inhibitor for 5 years is the standard treatment for postmenopausal hormone receptor–positive breast cancer. We investigated the effects of extending this treatment to 10 years on disease-free survival (DFS). PATI
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a6f2d4102ddb2138952c3a6670a822d8
https://doi.org/10.1200/jco.22.00577
https://doi.org/10.1200/jco.22.00577
Publikováno v:
Case Reports in Oncology. 14:1645-1651
We report a rare case of hereditary breast and ovarian cancer syndrome (HBOC) with pathogenic variants in both BRCA1 and BRCA2. The patient was a 78-year-old woman who visited the hospital after noticing a lump in her left breast 6 months before, whi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::51721d06b1dd6936bb687c0bf86f22c3
https://doi.org/10.1159/000520148
https://doi.org/10.1159/000520148